Week Ending March 28, 2022

Do Lung Cancer Patients Qualify for Disability Benefits?
A lung cancer diagnosis can be physically, emotionally, and financially disabling, and many lung cancer patients need financial assistance to help them stay afloat financially. Social Security Disability Insurance (SSDI) is a federally run benefit program earned by people who have worked and paid Social Security taxes on their earnings.1 Depending on the type and severity of your lung cancer, you may qualify for SSDI benefits.”

‘Extremely rare’ double lung transplant saves cancer patient: ‘I can’t stop smiling’
“Chicago surgeons have successfully performed an “extremely rare” double lung transplant on a 54-year-old man suffering from terminal cancer.”

St. Elizabeth Healthcare celebrates 20,000th lung cancer screening
“More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress (ELCC), 30 March-2 April 2022. The results of this study illustrate the value of registry data for improving lung cancer care.”

Proton Therapy for Lung Cancer
“Radiation therapy is one of the most common treatments for lung cancer. It’s often used in combination with other therapies, like surgery or chemotherapy.”

Toripalimab Improves PFS, OS in Non-Small Cell Lung Cancer
“The addition of toripalimab to chemotherapy significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced non-small cell lung cancer (NSCLC), according to results of the phase 3 CHOICE-01 study.1

St. Elizabeth Healthcare celebrates 20,000th lung cancer screening
“EDGEWOOD, Ky. — St. Elizabeth Healthcare has reached an impressive milestone in its fight against lung cancer: the 20,000th lung cancer screening.”

Starting Treatment for Small Cell Lung Cancer? Hear From an Oncology Nurse and a Cancer Patient.
“Cindy Cherry, MSN, AGNP-C, and cancer patient Dorothy T. share their experiences with cancer and how they approach chemotherapy treatment.”

New Study Examines Safety of Olaparib Plus Low-Dose Radiotherapy in SCLC
“Treatment locations in New York, New Jersey, and Florida are recruiting patients with mall cell lung cancer to receive olaparib and low-dose radiotherapy in a phase 1 clinical trial.”

Dr Melissa Johnson Discusses Barriers to NGS Testing in Lung Cancer
“Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, explains factors inhibiting uptake of next-generation sequencing testing among patients with lung cancer.”